Mode
Text Size
Log in / Sign up

Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathwaysPlant extracts may slow growth of head and neck cancer

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that while plant extracts show potential in HNSCC models, low bioavailability limits current clinical translation.

This systematic review evaluates the potential of various plant extracts, specifically resveratrol, curcumin, quercetin, and anthocyanins, in the management of head and neck squamous cell carcinoma (HNSCC). The review synthesizes evidence regarding their ability to induce apoptosis, inhibit cell proliferation, block metastasis, and reverse chemoresistance in HNSCC cells.

The authors identify that these effects are mediated through key regulatory signaling pathways, including the PI3K/AKT/mTOR, MAPK, and JAK/STAT3 cascades. These findings suggest that plant-derived compounds may have a role in modulating the tumor microenvironment and influencing cellular signaling in HNSCC.

Several limitations hinder the clinical translation of these findings. The authors note that plant extracts face challenges such as low bioavailability, unclear mechanisms of action, and complex chemical components that make standardization difficult. Consequently, the evidence is currently limited by these pharmacological hurdles.

For clinical practice, the findings suggest a potential for developing new anti-HNSCC drugs. The authors emphasize the need for advanced delivery systems, such as nano-drug delivery, and the integration of multi-omics with AI to overcome current pharmacological barriers and regulate the tumor microenvironment.

How this fits prior evidence

This systematic review addresses a gap in the understanding of botanical interventions for HNSCC. It expands upon previous findings where curcumin and resveratrol showed selective signals for modulating neuroinflammation, though those results were inconsistent in human trials. While this review identifies potential mechanisms for HNSCC, it does not provide clinical trial data for these compounds in humans.

Living with head and neck cancer is incredibly tough, especially when treatments like chemotherapy become less effective over time. Researchers are looking closely at how certain plant extracts, such as curcumin, resveratrol, quercetin, and anthocyanins, might change the way cancer cells behave. These compounds have shown the ability to stop cancer cells from multiplying, block them from spreading, and even help overcome resistance to chemotherapy in laboratory settings.

These effects happen by targeting specific signaling pathways inside the cells. These pathways, like the PI3K/AKT/mTOR and MAPK cascades, act like internal switches that tell cancer cells how to grow and survive. By interfering with these signals, the plant extracts may help slow down the progression of the disease.

While these results are encouraging, there are hurdles to overcome before these can be used as standard treatments. These compounds are complex and hard to standardize. They also have low bioavailability, which means the body has a hard time absorbing enough of the substance to be effective. More research is needed to find better ways to deliver these compounds to the right places in the body.

What this means for you:
Plant extracts like curcumin and resveratrol may help stop cancer growth and overcome chemoresistance in lab tests.

Common questions

What specific plant extracts were studied?

The study looked at several plant extracts, including resveratrol, curcumin, quercetin, and anthocyanins. These compounds were tested for their ability to stop cancer cells from multiplying and spreading, while also helping to reverse resistance to chemotherapy.

How do these plant extracts work against cancer?

These compounds work by affecting specific signaling pathways inside the cells, such as the PI3K/AKT/mTOR, MAPK, and JAK/STAT3 cascades. These pathways normally help cancer cells grow and survive, but the plant extracts can interfere with those signals.

Can these extracts be used as a treatment today?

Not yet. While the lab results are promising, these extracts have low bioavailability and are difficult to standardize. Because they are complex and have unclear mechanisms, more research is needed to develop them into reliable medical treatments.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Current treatments for head and neck squamous cell carcinoma (HNSCC) often encounter difficulties such as local tumor recurrence, distant metastasis, drug resistance, and significant toxic side effects. Plant extracts have become important resources for the development of anti-HNSCC drugs due to their multi-target action mechanisms, abundance of bioactive components, reversal of drug resistance, and high selectivity/low toxicity. The challenges faced by plant extracts during anti-cancer clinical translation include low bioavailability, unclear mechanisms of action, complex components, and difficulties in standardization. This review systematically summarizes the latest research progress on the anti-cancer effects of plant extracts in HNSCC and their regulatory signaling pathways. Various plant extracts, such as resveratrol, curcumin, quercetin, and anthocyanins, have anti-HNSCC effects, including inducing apoptosis, inhibiting proliferation, blocking metastasis, and reversing chemoresistance. The key underlying molecular events are primarily mediated by the PI3K/AKT/mTOR, MAPK, and JAK/STAT3 cascades. Future research directions for plant extracts in combating HNSCC include developing intelligent nano-drug delivery systems, integrating multi-omics with artificial intelligence, establishing innovative research models, and regulating the tumor microenvironment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.